Clinical and biological significance of RAS mutations in multiple myeloma

被引：128

作者：

Chng, W. J. ^{[1
,6
,7
]}

Gonzalez-Paz, N. ^{[2
]}

Price-Troska, T. ^{[2
]}

Jacobus, S. ^{[3
]}

Rajkumar, S. V. ^{[2
]}

Oken, M. M. ^{[4
]}

Kyle, R. A. ^{[2
]}

Henderson, K. J. ^{[2
]}

Van Wier, S. ^{[1
]}

Greipp, P. ^{[2
]}

Van Ness, B. ^{[5
]}

Fonseca, R. ^{[1
]}

机构：

[1] Mayo Clin, Dept Haematol Oncol, Scottsdale, AZ USA

[2] Mayo Clin, Div Haematol, Rochester, MN USA

[3] Dana Faber Canc Inst, Eastern Cooperat Oncol Grp, Ctr Stat, Boston, MA USA

[4] N Mem Canc Ctr, Dept Oncol, Minneapolis, MN USA

[5] Univ Minnesota, Dept Genet Cell Biol & Dev, Mineapolis, MN USA

[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore

[7] Natl Univ Singapore Hosp, Dept Haematol Oncol, Singapore 117548, Singapore

来源：

LEUKEMIA | 2008年 / 22卷 / 12期

关键词：

D O I：

10.1038/leu.2008.142

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2280 / 2284

页数：6

共 8 条

[1] High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis [J].

Bezieau, S ;

Devilder, MC ;

Avet-Loiseau, H ;

Mellerin, MP ;

Puthier, D ;

Pennarun, E ;

Rapp, MJ ;

Harousseau, JL ;

Moisan, JP ;

Bataille, R .

HUMAN MUTATION, 2001, 18 (03) :212-224

[2] Genetic events in the pathogenesis of multiple myeloma [J].

Chng, W. J. ;

Glebov, O. ;

Bergsagel, R. L. ;

Kuehl, W. M. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) :571-596

[3] Clinical significance of TP53 mutation in myeloma [J].

Chng, W. J. ;

Price-Troska, T. ;

Gonzalez-Paz, N. ;

Van Wier, S. ;

Jacobus, S. ;

Blood, E. ;

Henderson, K. ;

Oken, M. ;

Van Ness, B. ;

Greipp, P. ;

Rajkumar, S. V. ;

Fonseca, R. .

LEUKEMIA, 2007, 21 (03) :582-584

[4] Clinical and biologic implications of recurrent genomic aberrations in myeloma [J].

Fonseca, R ;

Blood, E ;

Rue, M ;

Harrington, D ;

Oken, MM ;

Kyle, RA ;

Dewald, GW ;

Van Ness, B ;

Van Wier, SA ;

Henderson, KJ ;

Bailey, RJ ;

Greipp, PR .

BLOOD, 2003, 101 (11) :4569-4575

[5] Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma? [J].

Greipp, PR ;

Trendle, MC ;

Leong, T ;

Oken, MM ;

Kay, NE ;

Van Ness, B ;

Kyle, RA .

LEUKEMIA & LYMPHOMA, 1999, 35 (1-2) :83-89

[6] Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation [J].

Kalakonda, N ;

Rothwell, DG ;

Scarffe, JH ;

Norton, JD .

BLOOD, 2001, 98 (05) :1555-1560

[7]

Oken MM, 1999, CANCER, V86, P957

[8] Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors [J].

Rasmussen, T ;

Kuehl, M ;

Lodahl, M ;

Johnsen, HE ;

Dahl, IMS .

BLOOD, 2005, 105 (01) :317-323

← 1 →